Ideaya Biosciences Inc (NASDAQ:IDYA) shares, rose in value on Friday, March 28, with the stock price down by -2.18% to the previous day’s close as strong demand from buyers drove the stock to $17.05.
Actively observing the price movement in the last trading, the stock closed the session at $17.43, falling within a range of $16.88 and $17.41. The value of beta (5-year monthly) was 0.753. Referring to stock’s 52-week performance, its high was $44.42, and the low was $16.95. On the whole, IDYA has fluctuated by -15.76% over the past month.
With the market capitalization of Ideaya Biosciences Inc currently standing at about $1.49 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-12.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that IDYA’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of IDYA currently trading nearly -7.38% and -18.17% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 31.80, while the 7-day volatility ratio is showing 4.78% which for the 30-day chart, stands at 5.38%. Furthermore, Ideaya Biosciences Inc (IDYA)’s beta value is 0.47, and its average true range (ATR) is 0.97.
A comparison of Ideaya Biosciences Inc (IDYA) with its peers suggests the former has fared considerably weaker in the market. IDYA showed an intraday change of -2.18% in last session, and over the past year, it shrunk by -59.89%%.
Data on historical trading for Ideaya Biosciences Inc (NASDAQ:IDYA) indicates that the trading volumes over the past 10 days have averaged 0.85 and over the past 3 months, they’ve averaged 894.26K. According to company’s latest data on outstanding shares, there are 86.50 million shares outstanding.
Nearly 7.65% of Ideaya Biosciences Inc’s shares belong to company insiders and institutional investors own 101.01% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 9.88 million shares as on 2025-03-14, resulting in a short ratio of 10.31. According to the data, the short interest in Ideaya Biosciences Inc (IDYA) stood at 1257.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 8.9 million. The stock has fallen by -33.66% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the IDYA stock heading into the next quarter.
